All sites C00-96,D32-33,D42-43,D45-47,D76 2379 90.4 4.4 2.7 0.8 1.7
Mouth, pharynx C00-14 59 98.0 1.3 - 0.3 0.3
  Lip C00 4 100.0 - - - -
  Tongue C02 9 100.0 - - - -
  Mouth, other C03-06 17 100.0 - - - -
  Salivary glands C07-08 4 95.5 - - - 4.5
  Pharynx C01,C09-14 25 95.9 3.3 - 0.8 -
Digestive organs C15-26 455 85.1 4.9 5.6 1.4 3.1
  Oesophagus C15 27 94.9 0.7 2.2 - 2.2
  Stomach C16 49 96.8 0.4 1.2 0.4 1.2
  Small intestine C17 11 98.2 1.8 - - -
  Colon C18 129 97.8 - 1.2 0.2 0.8
  Rectum, rectosigmoid C19-20 90 98.0 - 0.7 0.4 0.9
  Anus C21 3 100.0 - - - -
  Liver C22 47 74.3 7.6 12.2 2.1 3.8
  Gallbladder, bile ducts C23-24 11 52.6 17.5 8.8 5.3 15.8
  Pancreas C25 79 50.1 18.6 18.9 4.3 8.1
  Other digestive organs C26 7 55.9 20.6 2.9 5.9 14.7
Respiratory organs C30-39 269 65.3 21.0 8.4 1.9 3.3
  Nose, sinuses C30-31 6 100.0 - - - -
  Larynx, epiglottis C32 14 98.6 - 1.4 - -
  Lung, trachea C33-34 246 62.7 23.0 9.0 2.0 3.2
  Mediastinum, pleura C38 1 60.0 - - 20.0 20.0
Bone C40-41 4 95.5 - 4.5 - -
Melanoma of the skin C43 126 100.0 - - - -
Skin, non-melanoma C44 125 100.0 - - - -
Mesothelioma C45 14 98.6 - - - 1.4
Autonomic nervous system C47 1 100.0 - - - -
Soft tissues C48-49 13 98.4 - - 1.6 -
Breast C50 4 100.0 - - - -
Male genital organs C60-63 727 99.3 - 0.2 0.3 0.2
  Prostate C61 693 99.3 - 0.2 0.3 0.2
  Testis C62 28 99.3 - 0.7 - -
  Other male genital C60,C63 7 100.0 - - - -
Urinary organs C64-68 220 95.5 0.9 2.4 0.2 1.1
  Kidney C64 84 91.4 0.2 5.7 0.5 2.1
  Bladder and urinary tract2 C65-68 136 97.9 1.3 0.3 - 0.4
Eye C69 5 47.8 4.3 30.4 13.0 4.3
Brain, central nervous system C70-72,D32-33,D42-43 74 96.2 - 2.7 - 1.1
Thyroid gland C73 20 98.0 1.0 - 1.0 -
Other endocrine glands C74-75 3 85.7 - 14.3 - -
Illdefined or unknown C76,C80 31 62.6 13.5 11.6 2.6 9.7
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 228 86.3 7.5 1.1 1.0 4.2
  Hodgkin lymphoma C81 14 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 97 99.6 0.2 - - 0.2
  Malignant immunoproliferative diseases C88 4 83.3 - - 5.6 11.1
  Myeloma and other plasma cell tumors C90 33 76.8 8.5 6.7 3.0 4.9
  Leukaemia C91-95 54 75.7 18.8 - 1.1 4.4
  Myelodysplastic syndromes D46 10 48.0 14.0 - - 38.0
  Myeloproliferaitive neoplasms D45,D47 17 73.5 15.7 1.2 2.4 7.2
Not included above
  Basal cell carcinoma of the skin 670 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.